Wedbush Continues UnitedHealth Recommendation: Buy, $60 PT
Wedbush continued its UnitedHealth (NYSE: UNH) Buy rating and $60 price target in a research report published today.
In the report, Wedbush states, "[W]e continue to recommend UNH and view the stock as a top pick for long-term holders. We believe United is undervalued given its exposure to Medicare, Medicaid and HCIT growth."
Shares of UnitedHealth were trading at $55.84 at the time of posting, up 0.20% from Monday's market close.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.